Related Experiment Video
Updated: Apr 30, 2026

06:51
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
12.0K
Clostridium difficile phages: still difficult?
Katherine R Hargreaves1, Martha R J Clokie1
1Department of Infection, Immunity and Inflammation, University of Leicester Leicester, UK.
Frontiers in Microbiology
|May 9, 2014
Summary
Phage therapy offers a promising approach to combat Clostridium difficile infections. Researchers are exploring strategies to overcome challenges in developing C. difficile phages for therapeutic use.
Area of Science:
- Microbiology
- Virology
- Infectious Diseases
Background:
- Clostridium difficile infections (CDI) pose a significant public health threat due to emerging strains and antibiotic resistance.
- Phages, viruses that infect bacteria, have re-emerged as potential therapeutics against CDI.
- Developing effective phage therapies for CDI faces several challenges.
Purpose of the Study:
- To review the difficulties and strategies in developing Clostridium difficile phages for therapeutic applications.
- To highlight the potential benefits and ongoing research in phage therapy for CDI.
Main Methods:
- Review of epidemiological data on C. difficile diversity and distribution.
- Analysis of advances in molecular biology and phage-host interactions.
- Examination of genetic diversity and genomic insights of C. difficile phages.
Main Results:
- Phages show high specificity and efficacy in reducing C. difficile in vitro and in vivo.
- Genomic analysis reveals phage diversity, aiding in taxonomy and evolution understanding.
- Lack of strictly virulent C. difficile phages presents a therapeutic development hurdle.
Conclusions:
- Despite challenges, C. difficile phages hold significant therapeutic potential.
- Further research into whole-phage strategies and overcoming development hurdles is crucial.
- Phage therapy represents a viable future strategy to combat problematic C. difficile infections.
Related Concept Videos
Lysogenic Cycle of Bacteriophages
49.8K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
49.8K
DNA Bacteriophages
1.6K
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
1.6K
Lytic Cycle of Bacteriophages
60.2K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
60.2K
Viral Replication: Lysogenic Cycle
2.7K
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
2.7K
Bacterial Phylum Bacteroidota
885
The phylum Bacteroidota includes over 700 species classified into four primary orders: Bacteroidales, Cytophagales, Flavobacteriales, and Sphingobacteriales. These gram-negative, non-sporulating rods exhibit saccharolytic capabilities and can be aerobic or fermentative, encompassing obligate aerobes, facultative aerobes, and obligate anaerobes. Many species display gliding motility, though some are nonmotile or use flagella. The genus Bacteroides is well-studied due to its significant role in...
885
Viral Replication: Lytic Cycle
3.0K
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
3.0K

